Paul Sargos
@PaulSargos
Followers
2K
Following
20K
Statuses
6K
🇫🇷 Radiation Oncologist 🔆Head of Department, Radiotherapy, Bergonie, Bordeaux 🔅Radiotherapy, Charlebourg-La Defense, Paris 🔆CC-AFU, GETUG, GFRU, ESTRO
Bordeaux, France
Joined October 2018
PEACE 1 Multicentric RTQA just out in @RO_GreenJournal 💫 Overall, 84% of reviews were acceptable according to the trial protocol=confident in the results! 💫Major reasons for unacceptable delineation review were erroneous/ inconsistent CTV delineations
0
7
19
RT @PrafulRavi1: This work shows prognostic value for RCB with MFS for the first time in prostate cancer. If validated in #PROTEUS and othe…
0
1
0
RT @PrafulRavi1: 5yr MFS rates were 100% for RCB-0 (pCR), 90% for RCB-1 (<0.003cm3), 82% for RCB-2 (0.003-0.672cm3) and 63% for RCB-3 (>0.6…
0
2
0
RT @PrafulRavi1: We conducted a pooled analysis of >200pts treated on 5 neoadj ADT+ARPI trials led by Mary-Ellen Taplin. Overall 5yr MFS (b…
0
2
0
RT @cristian_udo: Is there a potential role for prostate SBRT < 5 fractions? Great to share our @EurUrolOncol TOFFEE meta-analysis compar…
0
15
0
RT @APCCC_Lugano: Two-fraction Versus Five-fraction Stereotactic Body Radiotherapy for Intermediate-risk Prostate Cancer: The TOFFEE Meta-a…
0
31
0
RT @yekeduz_emre: 🆕A systematic review & meta-analysis comparing SBRT, RFA, MWA, & cryoablation for localized renal cell carcinoma (RCC).…
0
31
0
RT @SbrtSean: Utilization of the SMAQ Questionnaire to Assess Adherence to Relugolix During Prostate SBRT
0
2
0
RT @PaulSargos: ⏩For operable patients, favorable histological response = 33%, with a local relapse-free survival rate of 90.5% at 1 year.…
0
1
0
RT @PaulSargos: 📍N=41 patients, 5 French centers. 📍RP2D : 100 mg olaparib twice daily. For the results...
0
1
0
RT @PaulSargos: In press in @Annals_Oncology ⏩ The RADIOSARP trial results : a phase Ib study of olaparib with concomitant radiotherapy in…
0
4
0
RT @PucheSanz: PSMA for detection of prostate cancer recurrence before Phoenix criteria. Is it really always the earlier the better?! J…
0
6
0
⚠️TOLERANCE : Grade 3 radiation dermatitis was the most frequent adverse event (34.1%). Two patients experienced grade 5 toxicity (4.8%) ⏩ effects of RT on vascular structures and potential for delayed wound healing in irradiated fields. ⏩ Read the paper for more details...
0
1
2